Aptose Biosciences (NASDAQ:APTO) Earns Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research note published on Tuesday,Benzinga reports. The brokerage currently has a $2.00 price target on the biotechnology company’s stock. Separately, StockNews.com initiated coverage on Aptose Biosciences in a research note on Saturday, December 7th. They set a […]
More Stories
XTX Topco Ltd Raises Stock Position in Cavco Industries, Inc. (NASDAQ:CVCO)
XTX Topco Ltd lifted its position in shares of Cavco Industries, Inc. (NASDAQ:CVCO – Free Report) by 20.5% during the...
XTX Topco Ltd Buys Shares of 8,398 Camtek Ltd. (NASDAQ:CAMT)
XTX Topco Ltd acquired a new stake in Camtek Ltd. (NASDAQ:CAMT – Free Report) in the third quarter, HoldingsChannel reports....
Pilgrim’s Pride Co. (NASDAQ:PPC) Stock Holdings Lifted by XTX Topco Ltd
XTX Topco Ltd lifted its stake in shares of Pilgrim’s Pride Co. (NASDAQ:PPC – Free Report) by 128.5% in the...
XTX Topco Ltd Makes New Investment in Cactus, Inc. (NYSE:WHD)
XTX Topco Ltd acquired a new stake in shares of Cactus, Inc. (NYSE:WHD – Free Report) in the 3rd quarter,...
XTX Topco Ltd Sells 21,231 Shares of Dayforce Inc (NYSE:DAY)
XTX Topco Ltd trimmed its stake in Dayforce Inc (NYSE:DAY – Free Report) by 67.8% in the 3rd quarter, HoldingsChannel...
UniFirst Co. (NYSE:UNF) Stock Holdings Lessened by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC reduced its position in UniFirst Co. (NYSE:UNF – Free Report) by 6.0% during the 3rd quarter,...